Simplify Logo
Biolinq

Biolinq

Biowearable biosensor platform for metabolic health

Manufacturing Supervisor

Full-Time
$85k - $101k/yr

+ Annual performance bonus + Incentive compensation

Junior, Mid, Senior
Bachelor's, Associate's
San Diego, CA, USA
In Person

Local travel may be required.

About the job

Requirements
  • A High School Diploma and at least 5 years of manufacturing work experience, or an Associate’s Degree and at least 2 years of manufacturing work experience, or a Bachelor’s Degree and at least 1 year of manufacturing work experience.
  • Ability to work in a production cleanroom environment.
  • Ability to stand, walk, sit, use hands to handle or feel, reach with hands and arms, climb or balance, stoop, kneel, crouch, see, talk, and hear; occasional lifting or moving of up to 15 pounds may be required.
Responsibilities
  • Manage daily manufacturing activities to achieve production plans and coordinate daily work-rotation schedules based on operational needs.
  • Own manufacturing-area performance metrics, including safety, quality, delivery, and cost.
  • Facilitate daily meetings to review progress, issues, and schedules.
  • Assist with designing an efficient equipment layout and material flow to maximize utilization.
  • Assist with reviewing and committing the daily production plan based on resource availability.
  • Provide initial support and resolve issues, escalating them through the department manager and supporting teams to minimize metric impact.
  • Ensure Good Manufacturing Practice and Good Documentation Practice compliance and safety adherence by the manufacturing team, and ensure assembler training reflects the latest revisions.
  • Hire, onboard, train, and assess the performance of manufacturing team members.
  • Manage overtime, attendance, disciplinary issues, daily supervision, and performance evaluations for the manufacturing team; provide coaching and performance communication to support development.
  • Analyze manufacturing data, identify trends, anomalies, and improvement opportunities, and apply methods to make manufacturing processes more efficient and effective.
  • Maintain the assigned area in an organized and clean condition using 5S practices.
  • Maintain cross-training skill assessments to ensure resource continuity.
  • Manage inventory levels and material replenishment for the assigned area.
  • Support testing, data collection, report writing, and documentation updates as needed.
  • Serve as a backup scheduler.
  • Perform other duties as assigned.
Desired Qualifications
  • Strong leadership skills, including the ability to set goals and provide respectful positive and constructive feedback to build relationships and improve business results.
  • Ability to work effectively within a team in a fast-paced, changing environment.
  • Strong verbal and written communication skills with the ability to communicate effectively at multiple organizational levels.
  • Ability to multitask, prioritize, and meet deadlines in a timely manner.
  • Strong organizational, planning, and follow-up skills and the ability to hold others accountable.
  • Flexibility to adjust to changing priorities.
  • Ability to collaborate across Engineering, Quality, Supply Chain, and Operations Leadership.
  • Strong coaching and people-leadership instincts, including scheduling and performance management across a growing, multi-shift team.
  • Ability to build and scale new operations responsibly while balancing speed with the rigor required for medical-device manufacturing.

About the company

Biolinq develops a biowearable platform with tiny under-skin sensors that monitor metabolic health, including glucose, by sensing multiple analytes. The sensors continuously collect data below the skin and transmit to an app or clinician for insights and personalized medicine. It differentiates by being a small, under-skin, multi-analyte system backed by university bioengineering research, not external wearables or single markers. Its goal is to gain regulatory approval and bring scalable, continuous metabolic health monitoring to patients.

Company Size

51-200

Company Stage

Series C

Total Funding

$316.4M

Headquarters

San Diego, California

Founded

2012

Get referred to Biolinq

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Biolinq closed a $100 million Series C on April 22, 2025, funding commercialization.
  • ADA 2026 data strengthened Shine after its 2025 FDA clearance, supporting physician credibility.
  • The new FDA category gives Biolinq a first-mover story against later needle-free entrants.

What critics are saying

  • Dexcom Stelo and Abbott Lingo already own OTC glucose monitoring in 2026.
  • Biolinq still lacks a predetermined change control plan, slowing future sensor upgrades.
  • If FDA or payers reject premium pricing, Biolinq stays a niche hardware company.

What makes Biolinq unique

  • Biolinq Shine won FDA De Novo on September 23, 2025, defining a new category.
  • Its autonomous, needle-free glucose sensor uses intradermal microsensors, not fingersticks or deep filaments.
  • Biolinq targets multi-analyte metabolic sensing, including glucose, lactate, and ketones, beyond single-metric CGMs.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Health Savings Account/Flexible Spending Account

Life Insurance

Disability Insurance

401(k) Retirement Plan

Paid Holidays

Paid Vacation

PTO

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

-2%
Yahoo Finance
Feb 2nd, 2026
Biolinq CEO predicts smart patches will dominate wearables after $100M Series C

Smart patches could become the next major wearables category after smartwatches and rings, according to Richard Yang, CEO of diabetes biosensor company Biolinq. Unlike watches that track digital biomarkers, smart patches monitor biomarkers linked to the body's internal chemistry. Biolinq raised $100 million in a Series C round in April 2025, bringing total funding to around $300 million. The company secured FDA de novo classification for its Shine biosensor in September 2025, making it the first needle-free continuous glucose monitoring device in the US market. The device uses microneedle arrays that only penetrate the skin's top layer. Yang says the consumer health domain is "hungry" for such technology. Biolinq plans to expand beyond diabetes monitoring, with future applications potentially tracking multiple health metrics simultaneously through semiconductor-based biosensor chips.

Live Forever Club CIC
May 5th, 2025
Biolinq raises $100M for glucose monitor

Biolinq, a California-based health tech company, has secured $100 million in Series C funding to advance its needle-free glucose monitor for Type 2 diabetes. The coin-sized patch uses electrochemical sensors to track glucose, lactate, and ketones without penetrating deeply into tissue. It also monitors sleep and activity, providing real-time feedback. The funding, led by Alpha Wave Ventures, will support development, U.S. regulatory submissions, and commercial rollout.

Venture Capital Investor
Apr 29th, 2025
Biolinq Secures $100 Million Series C

Biolinq, a maker of a biowearable glucose sensor platform, has closed a $100 million Series C financing round led by Alpha Wave Ventures, with participation from existing investors including RiverVest Venture Partners, AXA IM Alts, LifeSci Venture Partners, M Ventures, Hikma Ventures, Aphelion Capital, Taisho Pharmaceutical, and Features Capital.

FinSMEs
Apr 23rd, 2025
Biolinq Closes $100M Series C Financing

Biolinq, a San Diego, CA-based healthcare technology company providing precision multi-analyte biosensors, raised $100M in Series C funding.

Medical Device Network
Apr 23rd, 2025
Biolinq raises $100m to support US launch of intradermal glucose sensor

Biolinq has secured $100m in a Series C funding round to support the regulatory approval process in the US as it aims to launch its autonomous intradermal glucose sensor to the market.